
OLD Category: immuno-oncology
October 20, 2015 / Oncotarget
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
October 3, 2015 / Lancet Hematology
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
August 11, 2015 / Oncotarget
Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
July 16, 2015 / Oncotarget
Patient-derived cell models as preclinical tools for genome-directed targeted therapy
May 31, 2015 / J. Clinical & Cellular Immunol.
Interleukin-4 Expressed By Neoplastic Cells Provokes an Anti-Metastatic Myeloid Immune Response
May 22, 2015 / Cancer Immunology, Immunotherapy
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model
April 13, 2015 / Nat. Immunol.